Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 293, Issue 1, 2007, Pages

  Gaggar, Amit ^a,c,d   Li, Yao ^b   Weathington, Nathaniel ^c   Winkler, Margaret ^b   Kong, Michele ^b   Jackson, Patricia ^c   Blalock, J E ^c   Clancy, J P ^b  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d NONE   (United States)

Author keywords

Inflammation; Matrix metalloprotease; Neutrophil elastase; Protease

Indexed keywords

GELATINASE B; LEUKOCYTE ELASTASE; NEUTROPHIL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ACUTE RESPIRATORY FAILURE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTIC FIBROSIS; ENZYME ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SECRETION;

ADOLESCENT; ADULT; BODILY SECRETIONS; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; ENZYME ACTIVATION; ENZYME INHIBITORS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LEUKOCYTE ELASTASE; MALE; MATRIX METALLOPROTEINASE 8; MATRIX METALLOPROTEINASE 9; MODELS, BIOLOGICAL; RESPIRATORY SYSTEM; SPUTUM; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 34447522038     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00492.2006     Document Type: Article

References (38)

1. Arumugam S, Van Doren SR. Global orientation of bound MMP-3 and N-TIMP-1 in solution via residual dipolar couplings. Biochemistry 42: 7950-7958, 2006.
2. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 343: 269-280, 2000.
3. Birrer P, McElvaney NG, Rudeberg A, Sommer CW, Liechti-Gallati S, Kraemer R, Hubbard R, Crystal RG. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. Am J Respir Crit Care Med 150: 207-213, 1994.
4. Buttle DJ, Abrahamson M, Burnett D, Mort JS, Barrett AJ, Dando PM, Hill SL. Human sputum cathepsin B degrades proteoglycan, is inhibited by alpha 2-macroglobulin and is modulated by neutrophil elastase cleavage of cathepsin B precursor and cystatin C. Biochem J 276: 325-331, 1991.
5. Caterina NC, Windsor LJ, Bodden MK, Yermovsky AE, Taylor KB, Birkedal-Hansen H, Engler JA. Glycosylation and NH2-terminal domain mutants of the tissue inhibitor of metalloproteinases-1 (TIMP-1). Biochim Biophys Acta 1388: 21-34, 1998.
6. Cederqvist K, Sorsa T, Tervahartiala T, Maisi P, Reunanen K, Lassus P, Andersson S. Matrix metalloproteinases-2, -8, and -9 and TIMP-2 in tracheal aspirates from preterm infants with respiratory distress. Pediatrics 108: 686-692, 2001.
7. Davis PB, Drumm M, Konstan MW. State of the art: cystic fibrosis. Am J Respir Crit Care Med 154: 1229-1256, 1996.
8. Delacourt C, Le Bourgeois M, D'Ortho MP, Doit C, Scheinmann P, Navarro J, Harf A, Hartmann DJ, Lafuma C. Imbalance between 95 kDa type IV collagenase and tissue inhibitor of metalloproteinases in sputum of patients with cystic fibrosis. Am J Respir Crit Care Med 152: 765-774, 1995.
9. Dik WA, De Krijger RR, Bonekamp L, Naber BA, Zimmermann LJ, Versnel MA. Localization and potential role of matrix metalloproteinase-1 and tissue inhibitors of metalloproteinase-1 and -2 in different phases of bronchopulmonary dysplasia. Pediatr Res 50: 761-766, 2001.
10. Docherty AJ, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris TJ, Murphy G, Reynolds JJ. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 318: 66-69, 1985.
11. Doring G. The role of neutrophil elastase on chronic inflammation. Am J Respir Crit Care Med 150: S114-S117, 1994.
12. Dunsmore SE, Saarialho-Kere UK, Roby JD, Wilson CL, Matrisian L, Welgus HG, Parks WC. Matrilysin expression and function in airway epithelium. J Clin Invest 102: 1321-1331, 1998.
13. Ferry G, Lonchampt M, Pennel L, de Nanteuil G, Canet E, Tucker GC. Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury. FEBS Lett 402: 111-115, 1997.
14. Fujie K, Shinguh Y, Yamazaki A, Hatanaka H, Okamoto M, Okuhara M. Inhibition of elastase-induced acute inflammation and pulmonary emphysema in hamsters by a novel neutrophil elastase inhibitor FR901277. Inflamm Res 48: 160-167, 1999.
15. Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277: 2002-2004, 1997.
16. Hoshino M, Nakamura Y, Sim J, Shimojo J, Isogai S. Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. J Allergy Clin Immunol 102: 783-785, 1998.
17. Itoh Y, Nagase H. Preferential inactivation of TIMP-1 that is bound to the precursor MMP-9 by human neutrophil elastase. J Biol Chem 270: 16518-16521, 1995.
18. Kelly EA, Busse WW, Jarjour NN. Increased matrix metalloproteinase-9 in the airway after allergen challenge. Am J Respir Crit Care Med 162: 1157-1161, 2000.
19. Konstan MW, Berger M. Current understanding of the inflammatory process in cystic fibrosis: onset and etiology. Pediatr Pulmonol 24: 137-142, 1997.
20. McGuire JK, Li Q, Parks WC. Matrilysin mediates E-cadhedrin ectodomain shedding in injured lung epithelium. J Pathol 162: 1831-1843, 2003.
21. Muhlebach M, Stewart P, Leigh M, Noah TL. Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients. Am J Respir Crit Care Med 160: 186-191, 1999.
22. Okada Y, Watanabe S, Nakanishi I, Kishi J, Hayakawa T, Watorek W, Travis J, Nagase H. Inactivation of tissue inhibitor of metalloproteinases by neutrophil elastase and other serine proteinases. FEBS Lett 229: 157-160, 1988.
23. Ordonez C, Henig NR, Mayer-Hamblett N, Accurso FJ, Burns JL, Chmiel JF, Daines CL, Gibson RL, McNamara S, Retsch-Bogart GZ, Zeitlin PL, Aitken ML. Inflammatory and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosis. Am J Respir Crit Care Med 168: 1471-1475, 2003.
24. Ratjen F, Hartog CM, Paul K, Wermelt J, Braun J. Matrix metalloprotease in BAL fluid of patients with cystic fibrosis and their modulation by treatment by dornase-alpha. Thorax 57: 930-934, 2002.
25. Rice A, Banda MJ. Neutrophil elastase processing of gelatinase A is mediated by extracellular matrix. Biochemistry 34: 9249-9256, 1995.
26. Rowe SM, Miller S, Sorscher EJ. Cystic fibrosis. N Engl J Med 352: 1992-2001, 2005.
27. Sagel SD, Kapsner R, Osberg I. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis. Pediatr Pulmonol 39: 224-232, 2005.
28. Sagel SD, Kapsner R, Osberg I, Songtag MK, Accurso FJ. Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction. Am J Respir Crit Care Med 164: 1425-1431, 2001.
29. Shapiro SD. Diverse roles of macrophage matrix metalloproteinases in tissue destruction and tumor growth. Thromb Haemost 82: 846-849, 1999.
30. Shapiro SD, Goldstein NM, Houghton AM, Kobayashi DK, Kelley D, Belaaouaj A. Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice. Am J Pathol 163: 2329-2335, 2003.
31. Smith GN, Mickler EA, Hasty KA, Brandt KD. Specificity of inhibition of matrix metalloproteinase activity by doxycycline: relationship to structure of the enzyme. Arthritis Rheum 42: 1140-1146, 1999.
32. Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 200: 448-464, 2003.
33. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17: 463-516, 2001.
34. Stoller J, Aboussouan L. Alpha-1 antitrypsin deficiency. Lancet 365: 2225-2236, 2005.
35. Sweet DG, McMahon KJ, Curley AE, O'Connor CM, Halliday HL. Type I collagenases in bronchoalveolar lavage fluid from preterm babies at risk of developing chronic lung disease. Arch Dis Child Fetal Neonatal Ed 84: F168-F171, 2001.
36. Tanaka H, Miyazaki N, Oashi K, Tanaka S, Ohmichi M, Abe S. Sputum matrix metalloproteinase-9: tissue inhibitor of metalloproteinase-1 ratio in acute asthma. J Allergy Clin Immunol 105: 900-905, 2000.
37. Van den Steen PE, Proost P, Wuyts A, Van Damme J, Opdenakker G. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-α and leaves RANTES and MCP-2 intact. Blood 96: 2673-2681, 2000.
38. Weathington NM, van Houwelingen AH, Noerager BD, Jackson PL, Kraneveld AD, Galin FS, Folkerts G, Nijkamp FP, Blalock JE. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nat Med 12: 317-323, 2006.